n-acetylleukotriene-e4 and Asthma

n-acetylleukotriene-e4 has been researched along with Asthma* in 1 studies

Other Studies

1 other study(ies) available for n-acetylleukotriene-e4 and Asthma

ArticleYear
Inhaled budesonide inhibits OVA-induced airway narrowing, inflammation, and cys-LT synthesis in BN rats.
    Journal of applied physiology (Bethesda, Md. : 1985), 2000, Volume: 89, Issue:5

    The objective of the present investigation was to examine the effects of an inhaled glucocorticoid, budesonide, on antigen-induced production of cysteinyl leukotrienes (cys-LTs) and pulmonary inflammatory cell infiltration in the Brown Norway rat, an animal model of asthma. Two weeks after sensitization to ovalbumin, rats were treated with budesonide (2.5 mg/kg) 18 and 1 h before challenge with antigen. Budesonide abolished the late response to ovalbumin (P<0.02) and strongly inhibited the in vivo synthesis of N-acetyl-leukotriene E(4), an indicator of cys-LT synthesis, during this period (P<0.005). Both total bronchoalveolar lavage (BAL) cells (P<0.01) and BAL macrophages (P<0.005) were markedly reduced to approximately 25% of their control levels after treatment with budesonide. It can be concluded that inhibition of the antigen-induced late response in Brown Norway rats by budesonide is associated with reductions in both BAL macrophages and cys-LT synthesis. It is possible that the effect of budesonide on cys-LT synthesis is related to its effects on pulmonary macrophages.

    Topics: Administration, Inhalation; Airway Resistance; Animals; Asthma; Bile; Bronchoalveolar Lavage Fluid; Bronchodilator Agents; Budesonide; Cysteine; Leukotriene E4; Macrophages, Alveolar; Male; Ovalbumin; Rats; Rats, Inbred BN

2000